Essentials: Neuralink & Technologies to Enhance Human Brains | Dr. Matt MacDougall

Neuralink's first FDA-track goal is letting paralyzed patients control computers via motor-cortex signals, not restoring movement.

• First trial target: Neuralink's initial FDA submission targets quadriplegic patients, aiming to let them control a mouse/keyboard via motor-cortex signals alone, not restore limb movement.
• Robotic insertion required: Electrodes thinner than a human hair are placed by a robotic surgeon because human hands can't steadily navigate the brain's dense surface blood vessels.

Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.